Craig F. Jr. Courtemanche

Director Craig F. Jr. Courtemanche sells 56,122 shares (56.1K) for $2,533,544.78 via 10b5-1 plan at PCOR

Craig F. Jr. Courtemanche, a Director at Procore Technologies, executed 2 separate sales totaling 56,122 shares for $2,533,544.78 on 2026-06-10 at a blended average price of $45.14, reducing his non-derivative holdings from 975,826 to 919,704 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled in advance rather than discretionary. His post-transaction non-derivative holdings of 919,704 shares remain substantial, and he retains 224,492 shares in derivative securities (primarily stock options). Context: the stock is currently at $42.36, down 48.5% from its 52-week high of $82.32, and the company reported a net loss of $9.1M in its latest quarter despite 14.8% annual revenue growth. His prior sales at this ticker in May 2026 showed mixed near-term returns (ranging from -17.4% to -13.4% over 30 days), and his broader cross-ticker track record across 20 prior sells reflects an average 90-day return of -9.2%.

Director Courtemanche exercises options and sells all shares same-day; 8th open-market sale at PCOR with mixed prior timing.

Craig F. Courtemanche Jr., a director of Procore, exercised stock options and immediately liquidated the entire position in a same-day exercise-and-sell pattern—a transaction that generates no net change in his stake but produces over $2.8 million in proceeds. The sales occurred at prices ranging from approximately $50 to $52 per share, significantly above the $2.42 exercise price, capturing the spread between option grant and current market value. This is his 8th open-market sale at Procore over roughly three years, and his prior five sales at this company show mixed timing: two were well-timed exits (the stock subsequently declined), while three occurred before the stock rose further, suggesting inconsistent judgment about near-term direction. Against a backdrop of Procore trading well below its 52-week high and the company running unprofitable with negative earnings, the timing of this liquidation—converting vested options to cash rather than holding the shares—may simply reflect option-exercise mechanics and personal capital allocation rather than conviction about the company's trajectory.

Director Courtemanche sells 56,122 shares (56.1K) for $2,673,528.61 across 3 transactions at blended $47.64; stock has fallen -37.7% from 52-week high.

Courtemanche filed 3 separate sales totaling 56,122 shares (56.1K shares) for $2,673,528.61 ($2.7M) at an average price of $47.64, reducing his holdings by 5.7%. The stock has declined significantly since the transaction, trading at $49.60 (currently -37.7% from its 52-week high of $79.60) and down 13.2% over the prior 30 days and 31.0% over 90 days. At PCOR specifically, his 2 measurable prior sells both produced negative 90-day returns (-21.9% and -21.3%), both well-timed to subsequent declines. However, the company remains revenue-growing at +14.8% year-over-year against a $338.9M quarterly revenue base, though operating unprofitably with $-9.1M net income in the most recent quarter. The director retains substantial holdings of 927,580 shares post-sale. Investors should examine whether this sale reflects directional conviction about PCOR's near-term trajectory or routine portfolio management, particularly given the material price deterioration that has already followed other recent sales by this insider.

Director Courtemanche sold 56,121 shares for $3.2M at $57.23 avg; stock down 28.4% from highs, company unprofitable

Courtemanche Craig F. Jr., a Director, executed 3 separate sales totaling 56,121 shares (56.1K shares) for $3,211,888.66 ($3.2M) on 2026-03-10 at prices ranging from $56.99 to $58.41, with a blended average of $57.23. This represents a 5.7% reduction in his holdings (from 983.7K to 927.6K shares). At the PCOR ticker level, his prior 5 trades show mixed timing outcomes: only 1 of 3 measurable 90-day periods resulted in a decline after his sale, and his most recent two sells (2025-12-15) are down only modestly at the 30-day mark (-1.9% and -1.1%). The broader context reveals Procore is unprofitable (full-year net income was negative) despite 14.8% annual revenue growth, and the stock is trading 28.4% below its 52-week high of $79.60 after a 23.4% decline over the past 90 days—a period that includes recent insider sales that have not yet been followed by material further declines. The current price of $57.03 is essentially at the transaction prices, offering no timing signal in either direction.

Director Courtemanche sold 75,000 PCOR shares at avg $72.70 for $5.5M on 2025-12-15

Courtemanche Craig F. Jr. (Director) executed two separate sales totaling 75,000 shares for $5,452,572.87, reducing his holdings by 6.1%. At the transaction prices ($72.62 and $73.21), he was selling near the stock's current level of $73.41, well below the 52-week high of $88.33. Viewed against his prior trading at PCOR over the last 16 months, he has sold 5 times with mixed timing outcomes: 2 of his 4 measurable 90-day outcomes were well-timed (stock subsequently declined), while the other 2 saw subsequent gains of +21.2% and +18.8%. The company itself is facing headwinds—despite revenue growth of +21.2% year-over-year, it remains unprofitable with a net loss of $-9.1M in the latest quarter. His cross-ticker track record shows a 57.89% well-timed sell rate, modestly better than random but with an average 90-day return of -2.8% after his sales, suggesting his prior sales across all tickers have preceded small declines on average.

Director Courtemanche sells 300,000 PCOR shares ($21.6M) at $71.91; holds 657,123 post-sale (-31.3%)

Director Craig F. Courtemanche Jr. sold 300,000 shares of Procore at $71.91 on 2025-11-19, reducing his holdings by 31.3% to 657,123 shares and generating $21,573,000.00 in proceeds. The current price of $71.09 is 19.5% below the 52-week high of $88.33, and the stock has declined 2.0% over 30 days despite a positive 4.8% gain over 90 days. Courtemanche's prior five trades at Procore show a mixed pattern: three of the five sales (all on 2024-07-01) were well-timed at the 90-day mark with negative returns, while his two most recent 2024 sales (2024-11-21 and 2024-08-22) were poorly timed, with the stock advancing +7.2% and +0.6% respectively in the 30 days following. Procore remains unprofitable (net income of $-9.1M in the latest quarter) despite strong revenue growth of 21.2% annually, providing context for elevated valuation risk in a $11.1B market-cap company. The sale reflects a substantial reduction in a director's position at a critical point where the stock trades well below peak but the company's earnings path remains uncertain.

CEO Courtemanche sells 22,665 PCOR shares at $71.36; 4 of 5 prior PCOR sales showed negative 90d returns (well-timed).

Courtemanche Craig F. Jr., CEO & President, sold 22,665 shares at $71.36 on 2024-11-21, reducing holdings from 793,123 to 770,458 shares. The sale occurred at a price 6.9% below the 52-week high of $82.36. His prior trades at PCOR show a strong historical pattern: 4 of 5 earlier sales posted negative 90-day returns, indicating he has timed exits well at this ticker. At the cross-ticker level, his 90-day well-timed rate is 65.00% across 20 prior sells. PCOR trades at a significant scale ($11.4B market cap) but remains unprofitable, with negative $26.4M net income against $295.9M revenue, though revenue growth is strong at 31.9% year-over-year. The timing pattern across his PCOR history—4 of 5 prior sales preceding stock declines—establishes a measurable basis for monitoring whether this most recent sale precedes further price weakness.

CEO Craig F. Courtemanche Jr. sold 22,993 shares (23.0K) of PCOR at $59.14 on 2024-08-22; stock down -12.3% in 30 days

CEO Craig F. Courtemanche Jr. disposed of 22,993 shares for $1,359,806.02, reducing his stake from 816,116 to 793,123 shares (a -2.8% reduction in holdings). The stock has declined -12.3% over the following 30 days and currently trades at $61.68, down -25.1% from its 52-week high. His prior five trades at PCOR (all in June–July 2024) preceded modest 30-day gains (+2.3% to +8.7%), though 90-day outcomes are not yet measurable for most. Cross-ticker, his track record shows 20 prior sells with average 90-day returns of -6.0% and a 40.00% well-timed rate. The company reported $284.3M quarterly revenue (31.9% annual growth) but remains unprofitable with -$6.3M net income in the latest full fiscal year, suggesting execution or margin challenges despite strong top-line growth. The timing and magnitude of the August sale warrant observation against forward earnings inflection.

CEO Courtemanche sold 68,000 PCOR shares (11.4% of holdings) for $4.5M on 2024-07-01 at blended $65.59.

Craig F. Courtemanche Jr., CEO & President, executed 4 separate sales totaling 68,000 shares for $4,459,998.15 on 2024-07-01, reducing his holdings from 595,349 shares to 527,349 shares. The transactions occurred at prices ranging from $65.34 to $65.79, with a blended average of $65.59. The current stock price is $68.82, representing a 5.3% gain since the transaction date (30-day change). Across Courtemanche's cross-ticker track record, his prior sells averaged -18.5% 90-day returns with a 100% well-timed rate, indicating a historical pattern of selling before subsequent declines. At PCOR specifically, his 5 prior sales on 2024-06-03 showed mixed 30-day outcomes (+1.8% to +4.1%) with no completed 90-day measurement windows yet. The company reported negative net income of $-10,966,000 in the latest quarter despite 31.9% annual revenue growth, signaling continued unprofitability. The sale magnitude (11.4% of pre-transaction holdings) suggests a meaningful position reduction rather than routine rebalancing.